Public information presented according to the provisions of Directive 2001/18/EC
File:
Trial reference:
A phase II study evaluating the efficacy and the safety of first-line chemotherapy combined with TG4010 and nivolumab in patients with advanced non-squamous Non-Small-Cell Lung Cancer (NSCLC)
Doc type: